Search results

Measurement of the plasma recalcification time, in presence of the standardized aPTT (activated partial thromboplastin time) reagent (cephalin and activator), on human citrated plasma, to explore the activity of the intrinsic pathway coagulation factors (II, V, VIII, IX, X, XI, XII) and “anticoagulant” activities.

Measurement of the plasma recalcification time, in presence of the standardized aPTT (activated partial thromboplastin time) reagent (cephalin and activator), on human citrated plasma, to explore the activity of the intrinsic pathway coagulation factors (II, V, VIII, IX, X, XI, XII) and “anticoagulant” activities.

Measurement of the plasma recalcification time, in presence of the standardized aPTT (activated partial thromboplastin time) reagent (cephalin and activator), on human citrated plasma, to explore the activity of the intrinsic pathway coagulation factors (II, V, VIII, IX, X, XI, XII) and “anticoagulant” activities.

Measurement of the plasma recalcification time, in presence of the standardized aPTT (activated partial thromboplastin time) reagent (cephalin and activator), on human citrated plasma, to explore the activity of the intrinsic pathway coagulation factors (II, V, VIII, IX, X, XI, XII) and “anticoagulant” activities.

Activation of prothrombin.

Abnormal control for activated partial thromboplastin time (aPTT) assays.

For research use only.

Normal control for prothrombin time (PT) and activated partial thromboplastin time (aPTT) assays. May also be used as an alternative to in-house collected normal plasma pools.

Normal control for prothrombin time (PT) and activated partial thromboplastin time (aPTT) assays. May also be used as an alternative to in-house collected normal plasma pools.

Normal control for prothrombin time (PT) and activated partial thromboplastin time (aPTT) assays. May also be used as an alternative to in-house collected normal plasma pools.